Postpartum depression pill gets approval in a 1st for Canada – National
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is...
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is...
Calm, a digital mental health platform, has announced the international expansion of Calm Health, its evidence-based app now offering employer-provided...
As Canada reviews the lessons of the global COVID-19 pandemic, one thing has become abundantly clear: It's time to bolster...